Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults

NCT04866069 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
50
Enrollment
OTHER
Sponsor class

Stopped Although cellular responses to virus were satisfactory, neutralizing titres against virus were lower then expected levels

Conditions

Interventions

Sponsor

Osman ERGANIS, PhD, Prof

Collaborators